AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Processa Pharmaceuticals, Inc. Common
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG003MN60F5
1.81▼ 0.05 (-2.69%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.86
Day's Range
1.75 – 1.90
52-Week Range
0.11 – 8.88
Volume
34.9K
Avg Volume
134.4K
Share Statistics
Shares Outstanding
Employees
12
Exchange
XNAS
Listed
2013-10-07
Share count as of August 7, 2026

Processa Pharmaceuticals, Inc. Common (PCSA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Processa Pharmaceuticals, Inc. Common (PCSA)
What is Processa Pharmaceuticals, Inc. Common's Market Cap?
Processa Pharmaceuticals, Inc. Common's Market Cap is $5.1M, based on as-reported figures from SEC (XBRL) filings.
What is Processa Pharmaceuticals, Inc. Common's Net Income (TTM)?
Processa Pharmaceuticals, Inc. Common's Net Income (TTM) is -$13.4M, based on as-reported figures from SEC (XBRL) filings.
What is Processa Pharmaceuticals, Inc. Common's EBITDA?
Processa Pharmaceuticals, Inc. Common's EBITDA is -$12.9M, based on as-reported figures from SEC (XBRL) filings.
What is Processa Pharmaceuticals, Inc. Common's Diluted EPS (TTM)?
Processa Pharmaceuticals, Inc. Common's Diluted EPS (TTM) is -4.81, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PCSAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating Expenses
Research and Development Expense
Selling, General and Administrative Expense
Operating Loss
Other Income (Expense), net
Unrealized loss on digital assets——
Realized loss on digital assets———
Non-Operating Income (Expense)———
Interest Expense———
Total other income expenses———
Net Loss
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—